- Home
- PVLA vs MBI Comparison
PVLA vs MBI Comparison
Compare PVLA & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- MBI
- Stock Information
- Founded
- PVLA 2015
- MBI 1973
- Country
- PVLA United States
- MBI United States
- Employees
- PVLA N/A
- MBI N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- MBI Property-Casualty Insurers
- Sector
- PVLA Health Care
- MBI Finance
- Exchange
- PVLA Nasdaq
- MBI Nasdaq
- Market Cap
- PVLA 253.2M
- MBI 228.2M
- IPO Year
- PVLA N/A
- MBI 1987
- Fundamental
- Price
- PVLA $24.45
- MBI $4.41
- Analyst Decision
- PVLA Strong Buy
- MBI Buy
- Analyst Count
- PVLA 7
- MBI 2
- Target Price
- PVLA $46.29
- MBI $6.25
- AVG Volume (30 Days)
- PVLA 52.4K
- MBI 269.9K
- Earning Date
- PVLA 05-15-2025
- MBI 05-08-2025
- Dividend Yield
- PVLA N/A
- MBI N/A
- EPS Growth
- PVLA N/A
- MBI N/A
- EPS
- PVLA N/A
- MBI N/A
- Revenue
- PVLA N/A
- MBI $37,000,000.00
- Revenue This Year
- PVLA N/A
- MBI N/A
- Revenue Next Year
- PVLA N/A
- MBI N/A
- P/E Ratio
- PVLA N/A
- MBI N/A
- Revenue Growth
- PVLA N/A
- MBI 285.71
- 52 Week Low
- PVLA $11.17
- MBI $3.22
- 52 Week High
- PVLA $29.27
- MBI $7.46
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- MBI 44.44
- Support Level
- PVLA N/A
- MBI $4.13
- Resistance Level
- PVLA N/A
- MBI $5.00
- Average True Range (ATR)
- PVLA 0.00
- MBI 0.24
- MACD
- PVLA 0.00
- MBI -0.00
- Stochastic Oscillator
- PVLA 0.00
- MBI 18.97
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.